Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-12-11 Purchase |
2023-12-12 08:26 am |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
6,455 | $6.8523 | $44,232 | 4,559,233 (Indirect) |
View |
| 2023-12-07 Purchase |
2023-12-11 5:25 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
127,549 | $6.9809 | $890,411 | 4,552,778 (Indirect) |
View |
| 2023-11-29 Purchase |
2023-12-01 5:14 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
51,837 | $5.9702 | $309,477 | 4,425,229 (Indirect) |
View |
| 2023-11-27 Purchase |
2023-11-29 5:15 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
93,187 | $5.5941 | $521,294 | 4,373,392 (Indirect) |
View |
| 2023-05-15 Purchase |
2023-05-17 5:07 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
101,740 | $9.6462 | $981,404 | 4,280,205 (Indirect) |
View |
| 2021-06-10 Sale |
2021-06-11 5:00 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
11,229 | $36.15 | $405,971 | 4,178,465 (Indirect) |
View |
| 2021-06-08 Sale |
2021-06-10 6:35 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
150,000 | $35.99 | $5,397,810 | 4,189,694 (Indirect) |
View |
| 2021-06-07 Sale |
2021-06-09 6:49 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
72,400 | $34.15 | $2,472,583 | 4,339,694 (Indirect) |
View |
| 2021-06-03 Sale |
2021-06-07 4:31 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
34,507 | $33.28 | $1,148,373 | 4,412,094 (Indirect) |
View |
| 2021-05-28 Sale |
2021-06-02 4:32 pm |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
31,864 | $36.17 | $1,152,648 | 4,446,601 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-11 Option Award |
2024-06-13 9:01 pm |
N/A 2034-06-11 |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director 10% Owner |
18,040 | $0 | 4,579,603 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 6:04 pm |
N/A 2033-06-08 |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
16,280 | $0 | 4,296,485 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 1:23 pm |
N/A 2032-07-14 |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:05 pm |
2021-07-10 2031-06-10 |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-03-10 Other |
2021-03-12 4:40 pm |
N/A N/A |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
1,029,927 | $0 | 5,508,392 (Indirect) |
View |
| 2020-06-23 Option Award |
2020-06-24 4:48 pm |
2020-07-23 2030-06-23 |
Y-mAbs Therapeutics Inc. | YMAB | Wedell-Wedellsborg Johan Director |
16,000 | $0 | 16,000 (Direct) |
View |